AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Close
Create a link to this page
Copy and paste this link tag into your Web page or blog:
<a href="http://www.accessmylibrary.com/article-1G1-125892647/aldara-now-carcinoma-brief.html" title="Facts and information about Aldara now for carcinoma.(Brief Article)">Aldara now for carcinoma.(Brief Article)</a>
Close
Set up an RSS feed that alerts you when new articles from Chemist & Druggist are available.
Frequently asked questions about RSS feeds
Aldara now for carcinoma.(Brief Article)
Aldara (imiquimod) 5 per cent cream is now licensed to treat small superficial basal cell carcinoma in adults.
The topical immune modifier cream should be applied five days a week for six weeks, before normal sleeping hours ...
Related articles from newspapers, magazines, journals, and more
For more facts and information, see all results
- Aldara[TM] receives FDA approval for treating actinic keratosis.(Brief Article)
- Magazine article from: Dermatology Nursing June 1, 2005 700+ words
...Administration was granted marketing approval for Aldara (imiquimod) Cream, 5%, a topical...face or scalp in immunocompetent adults. Aldara Cream is the first immune response modifier...approved for AK. The FDA's approval of Aldara Cream for AK in early 2004 was based on...
- Lesion reduction of multiple actinic keratoses shown with Aldara[TM].(New...
- Magazine article from: Dermatology Nursing April 1, 2004 700+ words
...clinical results in Phase III studies of Aldara[TM] (imiquimod) Cream, 5%, an...baseline was 83% in patients treated with Aldara twice per week at 8 weeks post treatment...lesions in 45% of patients treated with Aldara compared to only 3% with vehicle. In...
- 3M Health Care's Aldara receives EMA approval.(Brief Article)
- Newspaper article from: Pharma Marketletter November 29, 2004 700+ words
...cleared its topical response modifier Aldara (imiquimod) cream 5% for the treatment...patients with a single BCC, treated with Aldara or placebo five times a week for six weeks...recorded in 82% of subjects treated with Aldara versus 3% in the placebo group; a statistically...
- Aldara[TM] (Imiquimod) Cream to treat basal cell carcinoma.(Clinical Trial...
- Magazine article from: Journal of Drugs in Dermatology October 1, 2003 700+ words
...Center (CC) This study will evaluate the effectiveness of Aldara (TM) (Imiquimod) Cream in treating basal cell carcinoma...Treatment or Intervention Phase Basal Cell Carcinoma Drug: Aldara[TM] (Imiquimod) Cream Phase IV Study ID Numbers: 020289...
- 3M's Aldara delayed for skin cancer.(3M Pharmaceuticals )(Brief Article)
- Newspaper article from: Pharma Marketletter April 19, 2004 700+ words
...Administration in response to its supplemental New Drug Application for Aldara (imiquimod) cream for the treatment of superficial basal cell...cleared for the new indication in the second half of this year. Aldara was recently approved for a new use by the FDA as a treatment...
- Aldara.(anticancer drugs)(Brief Article)
- Magazine article from: Medical Marketing & Media September 1, 2004 700+ words
Aldara (imiquimod) topical cream has received FDA approval for use in treating superficial basal cell carcinoma--a type of skin cancer...
- Aldara approved.(Rxs)(3M Pharmaceuticals)(Brief Article)
- Magazine article from: Chain Drug Review April 26, 2004 700+ words
3M Pharmaceuticals has obtained regulatory approval for the first immune response modifier to treat actinic keratosis. The patient-applied Aldara cream reportedly clears precancerous skin lesions.
- Intron-A/Aldara combination therapy for BCC.(Basal cell carcinoma)(SKIN...
- Magazine article from: Journal of Drugs in Dermatology February 1, 2008 700+ words
...is to see if BCC excluding the scalp and face can be treated successfully with a combination therapy of Intron[R]-A and Aldara[R]. Condition Intervention Phase Basal Cell Carcinoma Biological: Imiquimod Phase IV Excluding Scalp and Interferon alpha...